Peer Review History
| Original SubmissionMarch 6, 2025 |
|---|
|
PONE-D-25-09339Investigating the relationship between internal spinal alignment and back shape in patients with scoliosis using PCdare: a comparative, reliability and validation studyPLOS ONE Dear Dr. Kaiser, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohammad Amin Fraiwan Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 3. Please include a separate caption for each figure in your manuscript. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript written by Kaiser et al focuses on using PCdare to improve ease of interpretation for AIS. Overall, the clinical involvement and analysis is interesting, and the research aligns well with the guidelines in PLOS One. However, some essential revisions are needed before it is ready for publication. 1. It would be nice to have a reference supporting the claim that up to 3% of teenagers are affected by AIS (Line 58). Is this in the United States or globally? I specification on this would be helpful for context of AIS cases. Likewise, the authors mention that several studies have reported the incidence of radiation-induced cancer types is elevated in patients with AIS but only cites one reference. Is there more evidence to support the wording of “several”? 2. The PCdare software and the overview of what the software does should be explained in the introduction where Kaiser et al is mentioned. Perhaps a brief description of the software should be made after the sentence describing how the software can be used to register 3D surface scans on Line 73. This will really make the method and significance of this software stand out. 3. In regard to the time savings mentioned on Line 73, how much time was saved using such method? Having this specified may help show the significance of this approach compared to traditional methods. 4. The section written between Lines 101-112 is written out of order in respect to the content in Fig 1. It would naturally flow and read easier with the figure if Study 1 was mentioned first, Study 2, then to Study 3. 5. The authors mentioned on Line 123 that 7 images were used. Among them, 1 was with a normal spine, 2 with mild scoliosis, 3 with moderate, and 1 with severe. Was there a reason for the number of 7 images? And likewise, why were the patient breakdown unequal? 6. Were there considerations for statistical pairwise comparisons to generate a p value across students and clinicians to show if there is/lack of significance between the two groups for more informative results? 7. It appears that the equations written are in coding notation. If able, it would be more legible to present such calculations with the mathematical formulas, and referencing the packages/software used if any. I notice R is mentioned on Line 160, but not prior, which may be associated with the confusion. 8. Scale bar for the images in Fig 3. is missing. 9. Fig 5,6, and 7 should have all measurements plotted on the box plot to make it clear to the readers the variation of each reading, rather than the outliers only. It would further inform the type of distributions and clusters that are hidden in this current format. 10. Minor aesthetics comments on Fig 6 and 7. It appears Fig 6 is a screenshot, with the plot (left one) appearing to be clicked on prior to saving. Between these two figures, I see a minor dashed line in some plots, but not in others. What does this mean? 11. On Line 315-316, the authors mention how “a high correlation coefficient is to be expected even in patients with scoliosis.” Perhaps another sentence explicitly stating the reasoning may be informative to readers not fully aware of the field. 12. There are numerous areas that mention future work in the Discussion. (e.g., Lines 278, 290, 297, 301, 324, then the final paragraph in the Discussion). It may be easier to read if all mentions of future work is compartmentalized into one paragraph, perhaps at the end of the Discussion section into the paragraph along Lines 325-331. Reviewer #2: The authors highlighted the PCdare research software usage through 3 experimental studies, and investigated its reliability as a drawing tool for internal spinal alignment(ISL) in this current work. The experimental setup was well explained for the all 3 studies and it managed to help readers understand the effect of the markers and posture measurement. The approach, methodology and results support the objective of the work. The discussion also proposes explanations for the encountered errors with possible expansions in future work. It should be noted that code is made available but dataset is not shared but promised to be shared in a future data publication. There are few points that may help readers understand the reasoning behind some of the steps taken in the analysis, the first of which is the reasoning for the selection of 7 images only from the study 3 with 30 subjects available?, another followup explanation is for the reason for the class distribution [1,2,3,1]? is this a stratified random selection? or the two extreme cases (normal and severe) are easily examined and drawing of ISL poses no challenge for example?, it is not clear as to why such distribution is made assuming all 30 subjects have AIS. The use of median can be understood after examining the box plots but it would be clearer to readers if it is explained to understand the justification. Also, it might help if the reasons why images from study 1 and 2 are not used in the inter/intrarater reliability testing are explained, especially study 2 as it shows similar performance when compared to study 3(Table 5). Some extra details for the study protocol, what are the selection criteria for the participants and annotator?, would additional annotators provide better understanding of variability? Reviewer #3: This is an automated report for PONE-D-25-09339. This report was solicited by the PLOS One editorial team and provided by ScreenIT. ScreenIT is an independent group of scientists developing automated tools that analyze academic papers. A set of automated tools screened your submitted manuscript and provided the report below. Each tool was created by your academic colleagues with the goal of helping authors. The tools look for factors that are important for transparency, rigor and reproducibility, and we hope that the report might help you to improve reporting in your manuscript. Within the report you will find links to more information about the items that the tools check. These links include helpful papers, websites, or videos that explain why the item is important. While our screening tools aim to improve and maintain quality standards they may, on occasion, miss nuances specific to your study type or flag something incorrectly. Each tool has limitations that are described on the ScreenIT website. The tools screen the main file for the paper; they are not able to screen supplements stored in separate files. Please note that the Academic Editor had access to these comments while making a decision on your manuscript. The Academic Editor may ask that issues flagged in this report be addressed. If you would like to provide feedback on the ScreenIT tool, please email the team at ScreenIt@bih-charite.de. If you have questions or concerns about the review process, please contact the PLOS One office at plosone@plos.org. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Investigating the relationship between internal spinal alignment and back shape in patients with scoliosis using PCdare: a comparative, reliability and validation study PONE-D-25-09339R1 Dear Dr. Kaiser, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohammad Amin Fraiwan Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-09339R1 PLOS ONE Dear Dr. Kaiser, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mohammad Amin Fraiwan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .